Blood-Based Biomarkers for Alzheimer’s Disease in Primary Care: A Before and After Study
If you are a participating GP in Melbourne, Adelaide or Newcastle and have any queries in regards to your involvement in this study please click here for more information and the collection of resources can be found here.
Read more
Australians denied new treatment for Alzheimer’s Disease
The Australian Dementia Network (ADNeT) is very disappointed with the decision by the Therapeutic Goods Administration (TGA) to again reject the use of lecanemab in Australia. This decision denies Australians access to a therapy shown to slow decline by one third in Alzheimer’s Disease, the most common cause of dementia in Australia. The therapy has...
Read more
ADNeT NEWS – February 2025
Welcome to the first edition of the ADNeT newsletter for 2025! It was an exciting end to 2024 with the release the Australian National Dementia Action Plan (NDAP). It is a great step forwarding to setting solid goals for the future of dementia diagnosis, treatment, care and, critically, research. The vital role the ADNeT Registry...
Read more